SWA
Sutton Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $32.7K | Buy |
94
+15
| +19% | +$5.22K | 0.02% | 283 |
|
|
2023
Q2 | $27.8K | Hold |
79
| – | – | 0.01% | 304 |
|
|
2023
Q1 | $24.9K | Sell |
79
-7
| -8% | -$2.21K | 0.01% | 281 |
|
|
2022
Q4 | $24.8K | Hold |
86
| – | – | 0.01% | 608 |
|
|
2022
Q3 | $24.9K | Sell |
86
-1
| -1% | -$290 | 0.01% | 592 |
|
|
2022
Q2 | $24.5K | Hold |
87
| – | – | 0.01% | 598 |
|
|
2022
Q1 | $22.7K | Buy |
87
+7
| +9% | +$1.83K | 0.01% | 670 |
|
|
2021
Q4 | $17.6K | Buy |
80
+29
| +57% | +$6.37K | 0.01% | 748 |
|
|
2021
Q3 | $9.25K | Sell |
51
-12
| -19% | -$2.18K | ﹤0.01% | 939 |
|
|
2021
Q2 | $12.7K | Buy |
63
+5
| +9% | +$1.01K | ﹤0.01% | 831 |
|
|
2021
Q1 | $12.5K | Sell |
58
-10
| -15% | -$2.15K | ﹤0.01% | 810 |
|
|
2020
Q4 | $16.1K | Buy |
68
+7
| +11% | +$1.65K | 0.01% | 672 |
|
|
2020
Q3 | $16.6K | Hold |
61
| – | – | 0.01% | 596 |
|
|
2020
Q2 | $17.7K | Buy |
61
+3
| +5% | +$871 | 0.01% | 572 |
|
|
2020
Q1 | $13.8K | Buy |
58
+9
| +18% | +$2.14K | 0.01% | 570 |
|
|
2019
Q4 | $10.7K | Hold |
49
| – | – | 0.01% | 801 |
|
|
2019
Q3 | $8.3K | Hold |
49
| – | – | ﹤0.01% | 842 |
|
|
2019
Q2 | $8.99K | Buy |
49
+2
| +4% | +$367 | 0.01% | 801 |
|
|
2019
Q1 | $8.65K | Buy |
47
+5
| +12% | +$920 | 0.01% | 819 |
|
|
2018
Q4 | $6.96K | Hold |
42
| – | – | ﹤0.01% | 825 |
|
|
2018
Q3 | $8.1K | Hold |
42
| – | – | 0.01% | 825 |
|
|
2018
Q2 | $7.14K | Sell |
42
-113
| -73% | -$19.2K | 0.01% | 882 |
|
|
2018
Q1 | $25.3K | Hold |
155
| – | – | 0.02% | 478 |
|
|
2017
Q4 | $23.2K | Buy |
155
+117
| +308% | +$17.5K | 0.02% | 503 |
|
|
2017
Q3 | $5.78K | Hold |
38
| – | – | ﹤0.01% | 856 |
|
|
2017
Q2 | $4.9K | Buy |
38
+13
| +52% | +$1.68K | ﹤0.01% | 877 |
|
|
2017
Q1 | $2.73K | Sell |
25
-6
| -19% | -$656 | ﹤0.01% | 914 |
|
|
2016
Q4 | $2.28K | Sell |
31
-294
| -90% | -$21.7K | ﹤0.01% | 920 |
|
|
2016
Q3 | $28.3K | Buy |
325
+15
| +5% | +$1.31K | 0.03% | 370 |
|
|
2016
Q2 | $26.7K | Hold |
310
| – | – | 0.03% | 370 |
|
|
2016
Q1 | $24.6K | Buy |
+310
| New | +$24.6K | 0.02% | 385 |
|